Malignant salivary gland tumors

Area of Science:

• Oncology
• Head and Neck Surgery
• Radiation Oncology

Background:

• Salivary gland tumors are a diverse group of neoplasms with varying prognoses.
• Optimal treatment strategies for these tumors remain an area of active investigation.
• A retrospective analysis of long-term outcomes is crucial for refining therapeutic guidelines.

Purpose of the Study:

• To evaluate the effectiveness of different treatment modalities for salivary gland tumors.
• To compare the outcomes of surgery, radiotherapy, and combined-modality treatments.
• To identify factors influencing tumor control and survival rates in patients with salivary gland tumors.

Main Methods:

• Retrospective review of 403 patients diagnosed with salivary gland tumors between 1958 and 1980.
• Analysis of treatment modalities including surgery, radiotherapy, and combined therapy.
• Assessment of primary tumor control, regional and distant metastases, and cause-specific survival rates with a mean follow-up of 10 years.

Main Results:

• Combined surgery and radiotherapy achieved significantly higher primary tumor control rates (74% for parotid, 70% for submandibular, 73% for other sites) compared to surgery or radiotherapy alone.
• The 5- and 10-year cause-specific survival rates were 65% and 59% for parotid tumors, 61% and 48% for submandibular tumors, and 62% and 52% for tumors at other sites, respectively.
• Painless lump was the most common initial symptom (84%).

Conclusions:

• Combined modality treatment of surgery and radiotherapy demonstrates a clear advantage in controlling salivary gland tumors.
• This combination therapy should be considered the primary treatment approach for most salivary gland tumors.
• The findings support the integration of both surgical resection and radiation therapy for improved patient outcomes.